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VOutbreak
holera  is  still  a  major  health  challenge  in  sev-
ral countries  including  India.  Vibrio  cholerae, the
ausative agent  of  cholera  has  exhibited  several
hanging  pattern  in  its  biotype  as  well  as  in  drug
esistance  for  its  better  survival  and  infection  [1,2].
. cholerae  classical  biotype  strains  after  causing
arlier  six  cholera  pandemics  were  replaced  by  El
or biotype  in  the  seventh  pandemic.  The  vari-
nt V.  cholerae  O1  El  Tor  strain  possessing  cholera
oxin of  classical  biotype  appeared  after  O139,  and
as now  become  a  major  threat  worldwide  [2].
ikewise,  antimicrobial  susceptibility  pattern  also
as continuously  changed  for  V.  cholerae. Tetra-
ycline  is  an  important  broad  spectrum  antibiotic
sed for  the  prophylaxis  and  treatment  of  vari-
ty of  bacterial  infections  including  listed  biothreat
gents  like  Bacillus  anthracis, Francisella  tularen-
is, Yersinia  pestis  [3].  This  is  also  a  preferred
hoice for  control  of  cholera  as  recommended  by
HO. Earlier,  in  2007,  during  the  investigation
f a  large  cholera  outbreak  in  Rayagada  (19.09◦N
3.27◦E),  Orissa,  Eastern  India,  we  reported  a novel
utation  in  ctxB  gene  of  V.  cholerae  O1  El  Tor  iso-
ates indicating  the  enhanced  virulence  potential
4,5]. The  same  allelic  variation  has  recently  been
ound in  the  V.  cholerae  isolates  from  a  recent  out-
reak in  Haiti  [6].  These  isolates  from  India  were
ultidrug  resistant  but  sensitive  to  tetracycline  [7].
n this  communication,  we  report  the  emergence  of
etracycline  resistant  V.  cholerae  O1  El  Tor  Ogawa  in recent  cholera  outbreak  from  the  same  place  i.e.
ayagada  (19.09◦N  83.27◦E),  Orissa,  Eastern  India
uring September—October  2010.
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oi:10.1016/j.jiph.2011.09.007The  V.  cholerae  isolates  from  the  outbreak
linical samples  were  conﬁrmed  as  belonging  to
erogroup  O1,  biotype  El  Tor  and  serotype  Ogawa.
olymyxin  B  sensitivity,  Voges-Proskauer  test  and
stR biotyping  revealed  that  all  the  isolates  were  of
l Tor  biotype.  However,  cholera  toxin  (ctxB)  geno-
yping of  the  isolates  conﬁrmed  the  presence  of
txB of  classical  biotype  in  all  the  isolates.  Such  V.
holerae El  Tor  isolates  having  classical  ctxB  gene
re known  as  atypical  El  Tor  strains  and  cause  more
evere  disease  with  higher  case  fatality  rate  [2].
The  antimicrobial  susceptibility  of  the  isolates
s determined  by  the  disc  diffusion  method  on
ueller  Hinton  agar  (Difco  laboratories,  Sparks,
D)  using  antibiotic  impregnated  discs  from  Oxoid,
hermoelectron  LLS  India  Pvt  Ltd,  Mumbai,  India
evealed  resistance  for  co-trimoxazole  (25  g),
etronidazole  (5  g),  nalidixic  acid  (30  g), nitro-
urantoin  (300  g),  polymyxin-B  (300  g),  specti-
omycin  (100  g),  streptomycin  (10  g),  tetracy-
line (30  g),  trimethoprim  (5  g),  vancomycin
30 g)  and  vibriostatic  agent  2,4-diamino-6,7-
iisopropylpteridine  (O/129).  However,  the  iso-
ates were  susceptible  to  amoxicillin  (25  g),
zithromycin  (15  g),  chloramphenicol  (30  g),
iproﬂoxacin  (5  g),  erythromycin  (15  g),  gen-
amicin (10  g),  kanamycin  (30  g),  norﬂoxacin
10 g)  and  rifampicin  (5  g).  From  India,  tetra-
ycline resistance  has  been  reported  generally  in
. cholerae  O1  El  Tor  Inaba  strains  [8,9].  The
. cholerae  isolates  were  sensitive  to  tetracy-
line from  the  same  area  during  previous  cholera
utbreaks [7,10].  Tetracycline  resistance  among
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V.  cholerae  has  been  reported  from  several  other
regions  [11].  However,  during  the  last  decade,
plausibly this  is  the  ﬁrst  time  when  tetracycline
resistant V.  cholerae  strains  have  been  noticed  in
this area.
Additionally,  minimum  inhibitory  concentration
(MIC) of  tetracycline  was  found  to  be  16  g/ml
as determined  by  standard  protocol  [12].  The  MIC
of isolates  for  tetracycline  was  reduced  8-fold
from 16  g/ml  to  2  g/ml  in  presence  of  car-
bonyl cyanide  m-chlorophenylhydrazone  (CCCP)  in
broth at  sub-inhibitory  concentration  (0.5  g/ml)
and the  isolates  became  susceptible.  Tetracycline
resistance in  Gram-negative  bacteria  may  occur
due to  the  acquisition  of  genes  encoding  efﬂux
pump and  ribosomal  protection  proteins.  Most  of
the efﬂux  pumps  belong  to  major  facilitator  super-
family  (MFS)  which  export  tetracycline  from  the  cell
and exchange  a  proton  against  the  concentration
gradient [13].  CCCP  is  an  inhibitor  of  MFS  pro-
teins  as  it  disrupts  the  concentration  gradient.  The
isolates were  PCR  negative  for  the  reported  riboso-
mal protection  protein  Tet(M)  in  Vibrios.  Therefore,
the tetracycline  resistance  efﬂux  mechanism  may
be present  in  the  isolates.  However,  the  MIC  for
nalidixic  acid  (32  g/ml)  remained  unaffected  in
the presence  of  CCCP  indicating  some  other  mech-
anism  of  resistance  for  this  drug.  PCR  analysis
revealed the  presence  of  class  I  integrons  as  well  as
SXT elements  harbouring  antibiotic  resistance  traits
aadA2 and  str  (streptomycin),  dfrA1  (trimethoprim)
and sulII  (sulfomethoxazole)  in  all  the  isolates.
Class 1  integrons  and  SXT  elements  are  now  wide
spread  in  multiple  drug-resistant  V.  cholerae  strains
and have  been  described  as  vehicles  for  possible
horizontal acquisition  of  resistance  gene  cassettes
[14].
In general,  antibiotics  are  not  required  to
cure cholera  symptoms  and  only  recommended  in
severe cases  to  reduce  course  of  diarrhea.  Tetra-
cycline/doxycycline  are  commonly  used  antibiotics
in India.  Probably,  the  extensive  use  of  these
antibiotics has  resulted  in  the  emergence  of
tetracycline-resistance  in  V.  cholerae. Multi-drug
resistance  among  V.  cholerae  strains  limits  the
therapeutic  potential  of  these  drugs.  Many  cost
effective  antibiotics  like  co-trimoxazole  and  ery-
thromycin  have  already  become  ineffective  due
to bacterial  acquired  resistance.  Now,  resistance
for tetracycline  further  curtails  the  list  of  cost
effective  ﬁrst-line  drugs.  Antibiotics  resistance  is  a
serious public  health  concern.  Hence,  the  antibi-
otics use  in  a  cholera  endemic  area  should  be
closely monitored  and  any  emerging  resistance
among the  diarrheal  isolates  must  be  reportedLetter  to  the  Editor
mmediately  for  making  strategies  for  controlling
holera on  a global  basis.
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